Gerald T. Stanewick is Director at NASTECH PHARMACEUTICAL CO INC (NSTK). They have made 7 open-market trades across 1 company since 2006, most recently 2008-05-12.
CIK 0001293628
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $127K since 2006, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NSTK | 116,412 | — |
Shares reported on the most recent Form 4, priced at the 2008-05-12 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NSTK | BUY | 2008-05-12 | 2008-05-12 | $1.14 | $11K | N/A | N/A | N/A |
| NSTK | BUY | 2008-03-19 | 2008-03-19 | $2.40 | $12K | N/A | N/A | N/A |
| NSTK | SELL | 2007-09-10 | 2007-09-12 | $14.21 | $60K | N/A | N/A | N/A |
| NSTK | BUY | 2007-03-08 | 2007-03-09 | $10.73 | $21K | N/A | N/A | N/A |
| NSTK | BUY | 2006-12-08 | 2006-12-12 | $15.72 | $35K | N/A | N/A | N/A |
| NSTK | BUY | 2006-10-06 | 2006-10-10 | $15.75 | $47K | N/A | N/A | N/A |
| NSTK | SELL | 2006-04-05 | 2006-04-07 | $17.25 | $52K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.